Discover
KAPA
Kairos Pharma, Ltd.
0.81
100 x 0.81
200 x 0.82
bid
ask
-
0.15
15.55%
150 @ 07:56 PM
0.80 -0.01 (1.15%)
| Ytd | -83.70% | |
| 1y | -91.23% |
0.78
day range
1.00
0.81
52 week range
9.24
| Open | 0.91 | Prev Close | 0.96 | Low | 0.78 | High | 1.00 | Mkt Cap | 2.74M |
| Vol | 640.49K | Avg Vol | 602.89K | EPS | -1.96 | P/E | N/A | Forward P/E | -7.46 |
| Beta | 1.45 | Short Ratio | 0.13 | Inst. Own | 0.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.88 | 200-d Avg | 3.44 | 1yr Est | 9.00 |
| Income Statement | |||
| Operating Expenses | 1.42M | ||
| Research and Development Expense | 619.00K | ||
| Selling, General and Administrative Expense | 798.00K | ||
| Operating Income | -1.42M | ||
| Net Income | -1.39M | ||
| Net Income Common Stock | -1.39M | ||
| Net Income Common Stock (USD) | -1.39M | ||
| Consolidated Income | -1.39M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -1.39M | ||
| Earning Before Interest & Taxes (USD) | -1.39M | ||
| Weighted Average Shares | 21.42M | ||
| Weighted Average Shares Diluted | 21.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.63M | ||
| Cash and Equivalents (USD) | 2.63M | ||
| Current Assets | 3.17M | ||
| Total Assets | 4.46M | ||
| Current Liabilities | 265.00K | ||
| Total Liabilities | 265.00K | ||
| Accumulated Retained Earnings (Deficit) | -17.30M | ||
| Shareholders Equity | 4.19M | ||
| Shareholders Equity (USD) | 4.19M | ||
| Assets Non-Current | 1.28M | ||
| Trade and Non-Trade Payables | 265.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.00K | ||
| Net Cash Flow from Financing | -37.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.05M | ||
| Issuance (Purchase) of Equity Shares | 7.00K | ||
| Net Cash Flow from Operations | -1.01M | ||
| Share Based Compensation | 259.00K | ||